Nipro Corporation

8086.T · Tokyo Stock Exchange · JPY

1.331,00JPY

−67,50 (−4,83 %)Stand 11. Nov., 6:30

Vortag 1.398,50

Kennzahlen

Eröffnung
1.360,00
Vortag
1.398,50
Tagesspanne
1.318,50 – 1.362,50
52 Wochen
1.292,50 – 1.760,50
Volumen
1,6 Mio.
Ø Volumen
709.872
Börsenwert
217,08 Mrd. ¥
KGV
–
Gewinn je Aktie (TTM)
–
Dividendenrendite
–
Beta
-0,0
Nächste Zahlen
–

Finanzen

JPYFY 2025FY 2024FY 2023FY 2022FY 2021
Umsatz660,54 Mrd.644,59 Mrd.586,79 Mrd.545,2 Mrd.494,79 Mrd.
Herstellungskosten452,26 Mrd.450,93 Mrd.412,81 Mrd.379,3 Mrd.342,95 Mrd.
Bruttogewinn208,28 Mrd.193,66 Mrd.173,98 Mrd.165,9 Mrd.151,84 Mrd.
Forschung und Entwicklung021,67 Mrd.20,85 Mrd.19,67 Mrd.18,73 Mrd.
Vertrieb und Verwaltung170,66 Mrd.145,39 Mrd.130,8 Mrd.128,5 Mrd.109,22 Mrd.
Operatives Ergebnis37,63 Mrd.26,6 Mrd.22,34 Mrd.17,73 Mrd.23,88 Mrd.
EBITDA102,99 Mrd.92,58 Mrd.84,62 Mrd.70,02 Mrd.73,6 Mrd.
Nettogewinn13,5 Mrd.5,11 Mrd.11,11 Mrd.4,58 Mrd.13,46 Mrd.
Gewinn je Aktie (verwässert)73,3627,7860,3524,8577,42

Bewertung

Gerade nicht verfügbar.

Analysten

Einstufungen

Gerade nicht verfügbar.

Kursziel

Gerade nicht verfügbar.

Quartalszahlen

Gerade nicht verfügbar.

Dividenden und Splits

Gerade nicht verfügbar.

Aktiensplits

Gerade nicht verfügbar.

Eigentümer

Institutionen

Gerade nicht verfügbar.

Insider-Geschäfte

Gerade nicht verfügbar.

Vergleichbare Unternehmen

Gerade nicht verfügbar.

Über das Unternehmen

Nipro Corporation, along with its affiliated companies, operates across three primary business divisions: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device sector is dedicated to the development, production, and distribution of an extensive selection of disposable medical products. These offerings encompass specialized items for renal treatment, interventional procedures and anesthesia, injection and infusion therapies, dialysis, cardiopulmonary support, diabetes management, and cell culture applications. This division also markets products associated with artificial organs, as well as generic and kit-based medical supplies. Within its Pharmaceutical division, Nipro delivers innovative pharmaceutical combination products, such as dual chamber bags, pre-filled syringes, and half-type kits. It further extends its services through contract manufacturing for orally administered medications, injectable solutions, and topical preparations. The Pharma Packaging segment is focused on providing a comprehensive array of glass packaging solutions. This includes vials, ampoules, syringes, cartridges, and glass tubes. Additionally, this division manufactures glass forming machinery, glass bulbs for vacuum flasks, and various other essential pharmaceutical packaging components, such as rubber stoppers. An 'Other' business activity involves the provision of thermostable enzymes, which are vital for clinical chemistry applications. Nipro also offers business management services. Established in Osaka, Japan, in 1947, Nipro Corporation now serves a wide international customer base, spanning Japan, the Americas, Europe, and other regions across Asia.

CEO
Yoshihiko Sano
Mitarbeitende
38.593
Hauptsitz
Settsu, OS, JP
Sektor
Healthcare
Branche
Medical - Instruments & Supplies
Börsengang
1. Jan. 2001

Nachrichten

Gerade nicht verfügbar.

Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.